U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application If approved, Sunvozertinib as a single oral drug would offer a convenient and… CISION PRNewswireJanuary 7, 2025
Press ReleaseCIFF Guangzhou 2025 Preview: A Focus on Creative Design and Trade Upgrades GUANGZHOU, China, Jan. 7, 2025 /PRNewswire/ — The first phase of the… CISION PRNewswireJanuary 7, 2025
Press ReleaseTWSE Transforms Innovation Board into Asia's Premier Startup Platform TAIPEI, Jan. 7, 2025 /PRNewswire/ — The Taiwan Stock Exchange (TWSE) has… CISION PRNewswireJanuary 7, 2025
Press ReleaseTechECOVACS Robotic Vacuum Cleaner DEEBOT X8 with OZMO ROLLER Technology: A Leap Forward in Robotics at CES 2025 LAS VEGAS, Jan. 7, 2025 /PRNewswire/ — At CES 2025, ECOVACS showcases… CISION PRNewswireJanuary 7, 2025
Press ReleaseHL Mando and HL Klemove Jointly Participate in CES 2025 HL Heroes Video Revealed with the Slogan "Envision the Future" Showcasing Innovations… CISION PRNewswireJanuary 7, 2025
Press ReleaseTONCASH Secures Strategic Investment from TON Ventures to Scale Crypto Cashback Platform The investment will enable TONCASH to accelerate the onboarding of millions of… CISION PRNewswireJanuary 7, 2025
ATFX Launches Q1 2025 Trader Magazine: Key Insights for a Volatile Year HONG KONG, Jan. 7, 2025 /PRNewswire/ — As Q1 2025 begins, the… CISION PRNewswireJanuary 7, 2025
Press ReleaseBIPO Strengthens Global HR Tech Leadership with Third Recognition in Everest Group's PEAK Matrix® Assessment SINGAPORE, Jan. 7, 2025 /PRNewswire/ — BIPO, a leading global HR technology… CISION PRNewswireJanuary 7, 2025
